Patent · US Revoked

Adenoviral vectors of canine origin

US5891715A · kind A · utility

1Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 1995
Grant dateApr 6, 1999
Priority date
Expiry dateNov 17, 2015

Classification

  • Technology area (CPC —)General

Abstract

The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the therapeutic and/or surgical treatment of the human body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.